1. Home
  2. CCC vs TNGX Comparison

CCC vs TNGX Comparison

Compare CCC & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCC Intelligent Solutions Holdings Inc.

CCC

CCC Intelligent Solutions Holdings Inc.

N/A

Current Price

$4.46

Market Cap

3.1B

Sector

Technology

ML Signal

N/A

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$28.11

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCC
TNGX
Founded
1980
2014
Country
United States
United States
Employees
2185
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CCC
TNGX
Price
$4.46
$28.11
Analyst Decision
Buy
Strong Buy
Analyst Count
8
10
Target Price
$8.94
$21.78
AVG Volume (30 Days)
8.9M
4.7M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.89
EPS
N/A
N/A
Revenue
N/A
$62,384,000.00
Revenue This Year
$10.22
N/A
Revenue Next Year
$8.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.29
52 Week Low
$4.08
$4.60
52 Week High
$8.68
$34.39

Technical Indicators

Market Signals
Indicator
CCC
TNGX
Relative Strength Index (RSI) 38.84 54.16
Support Level $4.08 $19.74
Resistance Level $5.09 N/A
Average True Range (ATR) 0.25 2.56
MACD -0.02 0.58
Stochastic Oscillator 16.58 57.09

Price Performance

Historical Comparison
CCC
TNGX

About CCC CCC Intelligent Solutions Holdings Inc.

CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies, and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, AI-enabled digital workflows. It operates in a single segment being Domestic segment, which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in the United States and China. The majority of the revenue is generated from the United States.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: